Cardalis chewable tablets for dogs
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
CARDALIS® contains two active ingredients, benazepril hydrochloride and spironolactone, in a ratio of 1:8 respectively. CARDALIS® is supplied as brown oblong half-scored flavored chewable tablets. Benazepril belongs to the angiotensin-converting enzyme (ACE) inhibitor class of drugs. Spironolactone, and its active metabolites, act as specific aldosterone receptor antagonists. Both ACE inhibitors and aldosterone receptor antagonists act on the renin-angiotensin-aldosterone system.
Product Details
| DIN (Drug Identification Number) | 02542080 |
| Active Ingredients | two active ingredients, benazepril hydrochloride and spironolactone, in a ratio of 1:8 respectively |
| Approved For | Dog |
| Therapeutic Use | Renin angiotensine system agent |
| Form | Tablet |
| Route of Administration | Oral |
| Strength / Concentration | 2.5/20 mg mg |
| Pack Size | 30 Tab |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Ceva |
|---|---|
| DIN | 2542080, 2542102 |
| Active Ingredient | two active ingredients, benazepril hydrochloride and spironolactone, in a ratio of 1:8 respectively |
| Strength | 2.5/20 mg, 5/40 mg |
| Pack Size | 30 Tab |
Storage & Shipping
| Storage Conditions | Ambient |
|---|
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
